Favorable outcomes of localized synovial sarcoma patients with a high utilization rate of neoadjuvant and/or adjuvant chemotherapy

Synovial sarcoma (SS) is considered to be a chemosensitive, soft tissue sarcoma. Therefore, neoadjuvant and/or adjuvant chemotherapy (N/AC) is used for the treatment of high-risk SS patients. However, the role of N/AC remains controversial. The present study aimed to review the clinical outcomes of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Clin Oncol
Main Authors: Outani, Hidetatsu, Kakunaga, Shigeki, Hamada, Kenichiro, Takenaka, Satoshi, Imura, Yoshinori, Nagata, Shigenori, Tanaka, Takaaki, Tamiya, Hironari, Oshima, Kazuya, Naka, Norifumi, Kudawara, Ikuo, Araki, Nobuhito, Ueda, Takafumi, Yoshikawa, Hideki
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587004/
https://ncbi.nlm.nih.gov/pubmed/31281649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1863
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados